Brooks Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

29.46

26.25

24.70

24.70

24.70

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

85.61

43.28

32.08

40.30

39.51

Loan funds

Secured loans

6.06

5.04

5.66

4.92

8.16

Unsecured loans

-

-

-

-

-

Total

121.13

74.57

62.44

69.93

72.37

Uses of funds

Fixed assets

Gross block

24.43

22.62

21.82

20.66

19.70

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

10.45

8.95

6.81

5.53

4.74

Net block

13.98

13.67

15.01

15.14

14.96

Capital work-in-progress

-

-

-

1.12

0.02

Investments

90.52

46.86

46.85

46.84

46.81

Net current assets

Current assets, loans & advances

36.16

33.86

30.56

40.35

31.21

Less : current liabilities & provisions

19.53

19.82

29.98

33.53

20.62

Total net current assets

16.63

14.04

0.58

6.82

10.59

Miscellaneous expenses not written

-

-

-

-

-

Total

121.13

74.57

62.44

69.93

72.37

Notes:

Book value of unquoted investments

90.52

46.86

46.85

46.84

46.81

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

77.48

72.29

20.84

24.79

29.70

Number of equity sharesoutstanding (Lacs)

294.57

262.47

247.03

247.03

247.03